Focus: Infection Control

Rare E. coli found in Los Angeles County patient

Incident marks a first for California


A Los Angeles county resident was infected with a rare, drug-resistent E. coli bacteria, according to an article on the LA. Daily News website.

 

The incident marks a first for California and local public health officials issued an advisory.

 

“The appearance of mcr-1 in Los Angeles serves as a reminder of the importance of infection control measures and antibiotic stewardship,” a public health official said in an alert.

 

Last month, the health department mandated that CRE be reported by all acute care hospitals and skilled nursing facilities in Los Angeles County.

 

Read the article.

 

 



February 10, 2017


Topic Area: Infection Control


Recent Posts

Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


Geisinger Finds Success with Violence Prevention Efforts

Their safety measures included training staff in de-escalation, active-shooter response drills and equipping 6,000 employees with duress notification badges.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.